Bolden Therapeutics is a biotechnology company developing first-in-class therapeutics to treat central nervous system diseases.
Bolden Therapeutics's investors include Lifespan Vision Ventures, National Institute on Aging, Partners Resolute.
Bolden Therapeutics is headquartered in Providence, United States.
Bolden Therapeutics is a biotechnology company developing first-in-class therapeutics to treat central nervous system diseases.
Bolden Therapeutics is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Bolden Therapeutics — Funding & Investors." VCBacked, January 9, 2024, https://www.vcbacked.co/company/bolden-therapeutics. Accessed August 14, 2026.
VCBacked. (2024). Bolden Therapeutics — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/bolden-therapeutics
{{cite web |title=Bolden Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/bolden-therapeutics |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated